Becton Dickinson Price to Sales Ratio 2010-2024 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of December 20, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Becton Dickinson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-12-20 |
227.68 |
|
3.28 |
| 2024-09-30 |
239.98 |
$69.40 |
3.46 |
| 2024-06-30 |
231.70 |
$68.36 |
3.39 |
| 2024-03-31 |
244.35 |
$68.11 |
3.59 |
| 2023-12-31 |
239.82 |
$67.61 |
3.55 |
| 2023-09-30 |
253.24 |
$67.53 |
3.75 |
| 2023-06-30 |
257.73 |
$66.46 |
3.88 |
| 2023-03-31 |
240.78 |
$65.67 |
3.67 |
| 2022-12-31 |
246.39 |
$65.33 |
3.77 |
| 2022-09-30 |
215.11 |
$63.98 |
3.36 |
| 2022-06-30 |
237.19 |
$63.20 |
3.75 |
| 2022-03-31 |
248.74 |
$63.76 |
3.90 |
| 2021-09-30 |
228.31 |
$65.36 |
3.49 |
| 2021-06-30 |
225.16 |
$63.88 |
3.52 |
| 2021-03-31 |
224.34 |
$64.55 |
3.48 |
| 2020-12-31 |
230.08 |
$61.35 |
3.75 |
| 2020-09-30 |
213.21 |
$58.68 |
3.63 |
| 2021-12-31 |
234.40 |
$60.80 |
3.85 |
| 2020-06-30 |
218.51 |
$61.04 |
3.58 |
| 2020-03-31 |
209.17 |
$63.37 |
3.30 |
| 2019-12-31 |
246.74 |
$63.45 |
3.89 |
| 2019-09-30 |
228.79 |
$63.25 |
3.62 |
| 2019-06-30 |
227.27 |
$63.21 |
3.60 |
| 2019-03-31 |
224.48 |
$62.97 |
3.56 |
| 2018-12-31 |
201.91 |
$63.22 |
3.19 |
| 2018-09-30 |
233.12 |
$61.44 |
3.79 |
| 2018-06-30 |
213.34 |
$58.96 |
3.62 |
| 2018-03-31 |
192.36 |
$57.09 |
3.37 |
| 2017-12-31 |
189.38 |
$54.93 |
3.45 |
| 2017-09-30 |
172.76 |
$54.96 |
3.14 |
| 2017-06-30 |
171.39 |
$55.65 |
3.08 |
| 2017-03-31 |
160.53 |
$56.62 |
2.84 |
| 2016-12-31 |
144.30 |
$57.15 |
2.52 |
| 2016-09-30 |
155.97 |
$57.54 |
2.71 |
| 2016-06-30 |
146.63 |
$57.43 |
2.55 |
| 2016-03-31 |
130.75 |
$57.23 |
2.28 |
| 2015-12-31 |
132.11 |
$53.33 |
2.48 |
| 2015-09-30 |
113.26 |
$50.66 |
2.24 |
| 2015-06-30 |
120.39 |
$46.86 |
2.57 |
| 2015-03-31 |
121.52 |
$42.84 |
2.84 |
| 2014-09-30 |
95.51 |
$42.75 |
2.23 |
| 2014-06-30 |
98.82 |
$42.16 |
2.34 |
| 2014-03-31 |
97.35 |
$41.54 |
2.34 |
| 2013-12-31 |
91.44 |
$41.14 |
2.22 |
| 2013-09-30 |
82.36 |
$40.49 |
2.03 |
| 2013-06-30 |
80.97 |
$39.35 |
2.06 |
| 2013-03-31 |
77.94 |
$38.66 |
2.02 |
| 2012-12-31 |
63.38 |
$37.76 |
1.68 |
| 2012-09-30 |
63.27 |
$36.66 |
1.73 |
| 2012-06-30 |
59.85 |
$35.51 |
1.69 |
| 2012-03-31 |
61.79 |
$34.60 |
1.79 |
| 2011-12-31 |
59.11 |
$33.93 |
1.74 |
| 2011-09-30 |
57.64 |
$33.42 |
1.72 |
| 2011-06-30 |
67.40 |
$31.93 |
2.11 |
| 2011-03-31 |
61.98 |
$30.88 |
2.01 |
| 2010-12-31 |
65.46 |
$29.83 |
2.19 |
| 2010-09-30 |
57.10 |
$29.61 |
1.93 |
| 2010-06-30 |
51.83 |
$29.83 |
1.74 |
| 2010-03-31 |
60.03 |
$29.55 |
2.03 |
| 2009-12-31 |
59.84 |
$29.10 |
2.06 |
| 2009-09-30 |
52.68 |
$31.82 |
1.66 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.714B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
